CLINICAL_TRIALS
trial_result
· 2017-11-07
Clinical Trial Update: Evaluation of FeNO During and Following Acute COPD Exacerbation
Summary
A study evaluating exhaled nitric oxide (FeNO) during and after acute COPD exacerbations was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Wake Forest University | Conditions: Chronic Obstructive Pulmonary Disease | Status: TERMINATED